Viewing StudyNCT05439499



Ignite Creation Date: 2024-05-06 @ 5:47 PM
Last Modification Date: 2024-10-26 @ 2:36 PM
Study NCT ID: NCT05439499
Status: RECRUITING
Last Update Posted: 2022-07-06
First Post: 2022-06-24

Brief Title: This is a Multicenter Randomized Double-blind Placebo-controlled Phase III Clinical Study Evaluating the Efficacy and Safety of FCN-437c Versus Placebo in Combination With Letrozole or Anastrozole Goserelin in Women With HR and HER2- Advanced Breast Cancer
Sponsor: Ahon Pharmaceutical Co Ltd
Organization: Ahon Pharmaceutical Co Ltd

Key Dates - Follows AllAPIJSON File Order

Start Date: 2022-03-02
Start Date Type: ACTUAL
Primary Completion Date: 2024-09-20
Primary Completion Date Type: ESTIMATED
Completion Date: 2025-03-02
Completion Date Type: ESTIMATED
First Submit Date: 2022-06-24
First Submit QC Date: June 26 2022
Study First Post Date: 2022-06-30
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2022-07-04
Last Update Post Date: 2022-07-06
Last Update Post Date Type: ACTUAL